- Home
- POAI vs ABVC Comparison
POAI vs ABVC Comparison
Compare POAI & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- ABVC
- Stock Information
- Founded
- POAI 2002
- ABVC 2015
- Country
- POAI United States
- ABVC United States
- Employees
- POAI N/A
- ABVC N/A
- Industry
- POAI Industrial Specialties
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- ABVC Health Care
- Exchange
- POAI Nasdaq
- ABVC Nasdaq
- Market Cap
- POAI 9.7M
- ABVC 9.9M
- IPO Year
- POAI N/A
- ABVC N/A
- Fundamental
- Price
- POAI $1.45
- ABVC $0.70
- Analyst Decision
- POAI Hold
- ABVC
- Analyst Count
- POAI 1
- ABVC 0
- Target Price
- POAI N/A
- ABVC N/A
- AVG Volume (30 Days)
- POAI 483.7K
- ABVC 1.2M
- Earning Date
- POAI 03-27-2025
- ABVC 03-12-2025
- Dividend Yield
- POAI N/A
- ABVC N/A
- EPS Growth
- POAI N/A
- ABVC N/A
- EPS
- POAI N/A
- ABVC N/A
- Revenue
- POAI $1,484,223.00
- ABVC $509,788.00
- Revenue This Year
- POAI N/A
- ABVC N/A
- Revenue Next Year
- POAI $569.48
- ABVC N/A
- P/E Ratio
- POAI N/A
- ABVC N/A
- Revenue Growth
- POAI N/A
- ABVC N/A
- 52 Week Low
- POAI $0.55
- ABVC $0.40
- 52 Week High
- POAI $3.67
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- POAI 50.83
- ABVC 75.66
- Support Level
- POAI $1.39
- ABVC $0.40
- Resistance Level
- POAI $1.97
- ABVC $0.88
- Average True Range (ATR)
- POAI 0.14
- ABVC 0.08
- MACD
- POAI -0.02
- ABVC 0.02
- Stochastic Oscillator
- POAI 14.88
- ABVC 62.42
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.